Coloplast Shows Strength in 1Q; Our FVE Is Unchanged
Coloplast’s fiscal first quarter generally met our expectations on the top and bottom lines, and we’re holding steady on our fair value estimate. With quarterly organic growth up 8% year over year, Coloplast once again outpaced market growth in ostomy, continence care, and urology. Although the acquisition of U.S. distributor Comfort Medical helped boost growth, the healthy underlying growth reflected solid demand and ongoing adoption of new products. Even with rival ConvaTec regrouping to impro...
Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.
Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.
We have operations in 27 countries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.